| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518545A Novel, ascorbic acid compounds, methods of synthesis and application use thereof |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/04/2004 | CN1518540A Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-a, a-dimethylbenzene acetic acid and its hydrochloride |
| 08/04/2004 | CN1518479A Stabilization and terminal sterilization of phospholipid formulations |
| 08/04/2004 | CN1518469A Dermatological formulations |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518462A Pharmaceutical formulation |
| 08/04/2004 | CN1518461A Medicinal compositions |
| 08/04/2004 | CN1518460A Composition comprising PDE-4 inhibitor and H1-receptor antagonist and use thereof for manufacture of medicament for treatment of respiratory diseases |
| 08/04/2004 | CN1518458A Graft rejection inhibitors |
| 08/04/2004 | CN1518454A Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatary activity and anti-atherogenic activity |
| 08/04/2004 | CN1518453A Anti-stress agents |
| 08/04/2004 | CN1518452A Oral delivery of macromolecules |
| 08/04/2004 | CN1518451A Identifying and treatment of purastic fungi of organism |
| 08/04/2004 | CN1518450A Use of adenosine analogues for treatment of insulin resisttance syndrome and diabetes |
| 08/04/2004 | CN1518449A Pediatric formulation of gatifloxacin |
| 08/04/2004 | CN1518448A Antihistamines for treatment of nasal congestion and nasal obstruction |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1518446A Repinotan kit |
| 08/04/2004 | CN1518445A Treatment of sexual dysfunction |
| 08/04/2004 | CN1518444A Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 08/04/2004 | CN1518443A Stable pharmaceutical composition of pravastatin |
| 08/04/2004 | CN1518441A Particles for inhalation having rapid release properties |
| 08/04/2004 | CN1517380A Composition for using polywax with biological absorptivity and medical device |
| 08/04/2004 | CN1517361A Diosgenin butanedioic acid monoester derivative and its preparation method and application |
| 08/04/2004 | CN1517360A Diosgenin amino and ester derivative and its preparation method and application |
| 08/04/2004 | CN1517349A Two new compounds for treating impotence |
| 08/04/2004 | CN1517347A Antivirus nucleoside derivative |
| 08/04/2004 | CN1517337A Preparation method of ropivacaine methanesulfonate and its compound and preparation |
| 08/04/2004 | CN1517334A Improvement of synthesis process ofhypoglycemic medicine Nagelinei |
| 08/04/2004 | CN1517122A Medicine for treating coronary heart disease and its preparation method |
| 08/04/2004 | CN1517097A Bambbo leaf flavone freeze dried powser injection, its preparation method and application |
| 08/04/2004 | CN1517096A Application of bamboo leaf flavone in preparation of medicine |
| 08/04/2004 | CN1517095A Anti-infection medicine |
| 08/04/2004 | CN1517094A Monosialic acid tetrahexose ganglioside liposome complex preparation |
| 08/04/2004 | CN1517093A Sodium glycerophosphate injection and its manufacturing method and application |
| 08/04/2004 | CN1517092A Compound preparation fortreating psoriasis vulgaris and its preparation process |
| 08/04/2004 | CN1517091A Progesterone preparation and its preparation method |
| 08/04/2004 | CN1517090A Animal use suspensoid injection or emulsion containing antibacterial medicine |
| 08/04/2004 | CN1517089A Indometacin eyedrops |
| 08/04/2004 | CN1517088A Ginkgo leaf extract injection and its preparation method |
| 08/04/2004 | CN1517087A Txoxerutin for preparing ege drops to treat different kinds of egeground affection or vision fatigue |
| 08/04/2004 | CN1517086A Medical use of poly hydroxy flavone derivatives |
| 08/04/2004 | CN1517085A Multi-microelement injecta and its preparation method and application |
| 08/04/2004 | CN1160469C Identification of genes |
| 08/04/2004 | CN1160366C Novel method for isomerising the 10-methyl radical of erythromycin derivatives |
| 08/04/2004 | CN1160364C Drugs, foods or drinks with the use of algae-derived physiologically active substances |
| 08/04/2004 | CN1160360C Oxazonaphthalone compounds for enhancing synaptic response |
| 08/04/2004 | CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160355C Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 08/04/2004 | CN1160353C Prepn. of 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-asymmetric indacene |
| 08/04/2004 | CN1160352C Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity, preparation method and its composition and use |
| 08/04/2004 | CN1160348C Aryl-{4-fluoro-4-{(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 08/04/2004 | CN1160345C Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 08/04/2004 | CN1160333C Ester of pipperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 08/04/2004 | CN1160332C N-aryloxyethylamine derivatives for treatment of depression |
| 08/04/2004 | CN1160331C Process for preparing photoactivated (-) yellow skin amide |
| 08/04/2004 | CN1160330C N-substituted 2-cyanopyrrolidines compound |
| 08/04/2004 | CN1160329C O-thiocarbamoyl-aminoalkanol copmound, their pharmaceutically acceptable salt and process for preparing the same |
| 08/04/2004 | CN1160323C New benzenesulfonylamine derivatives, process for preparating them and pharmaceutical compositions containing them |
| 08/04/2004 | CN1160312C Substituted alkyl tetramine dervative |
| 08/04/2004 | CN1160309C Alkyloxyamino substitued fluorenones and their use as protein kinase C inhibitors |
| 08/04/2004 | CN1160128C Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester |
| 08/04/2004 | CN1160115C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 08/04/2004 | CN1160100C Ointment for treating burn and scald |
| 08/04/2004 | CN1160088C Extraction method of pharmaceutical composition and cosmetic composition |
| 08/04/2004 | CN1160087C Compsns. of recovering and promoting skin protection functions and its evaluating method |
| 08/04/2004 | CN1160085C New lactic acide fungus preparation having biological purifying activity |
| 08/04/2004 | CN1160082C Medicine for curing burn and scald and its preparing method |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/04/2004 | CN1160080C Use of algin oligosaccharide for preparing medicine for preventing dementia by hyoscine |
| 08/04/2004 | CN1160078C sialic acid, its salt, pharmaceutical use of its polymer or salt of polymer |
| 08/04/2004 | CN1160077C External-used medicine containing phosphonomycin calcium and its application |
| 08/04/2004 | CN1160076C Pharmaceutical composition comprising bisphosphonic acid |
| 08/04/2004 | CN1160075C Use of heterocyclic amide compound for preparing IgE antibody production inhibitors |
| 08/04/2004 | CN1160074C Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 08/04/2004 | CN1160073C Use of halofuginone for preparing medicine for treating cirrhosis |
| 08/04/2004 | CN1160072C MAG expression promoters |
| 08/04/2004 | CN1160071C Use of substiuted 2,4-imidazolidinedione compounds as analgesics |
| 08/04/2004 | CN1160070C A pharmaceutical composition containing kynurbenine and thymine or tryptopham and thymine |
| 08/04/2004 | CN1160069C Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 08/04/2004 | CN1160068C Inihibition of lipoprotein oxidation |
| 08/04/2004 | CN1160067C Ginkgo lactone capsule and its prepn. method |
| 08/04/2004 | CN1160066C Preparing process of freeze dried ginkgolactone injection |
| 08/04/2004 | CN1160065C Use of preparing medicine for treating depression by low affinity NMDA antagonists |
| 08/04/2004 | CN1160064C Selective antibiotic composition |
| 08/04/2004 | CN1160063C Method for coating slow releasing coat of ibudilast sustained micropill |
| 08/04/2004 | CN1160062C Pharmaceutical formulation comprising omeprazole |
| 08/04/2004 | CN1160061C Core tablet for controlled release of gliclazide after oral administration |
| 08/04/2004 | CN1160060C Compressed compositions comprising clarified xanthan gum |
| 08/04/2004 | CN1160059C Process of generating submicron particles of water-insuluble compounds |
| 08/04/2004 | CN1160058C 附聚物 Agglomerates |